RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VIVOS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026
- Market cap
- $23.44M
- P/E (TTM)
- –
- Dividend yield
- –
VIVOS INC revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | % of revenue | YoY |
|---|---|---|---|---|
| IsoPet [Member] | $143.03K | – | 209.2% | – |
| Services - Treatments [Member] | $88.88K | $30.00K | 130.0% | +196.3% |
| Certification [Member] | $37.48K | – | 54.8% | – |
| Polymer [Member] | $1.06K | – | 1.5% | – |
| Freight [Member] | $1.05K | – | 1.5% | – |
| Discount - Certifications [Member] | -$10.00K | – | -14.6% | – |
| Discount - Services [Member] | -$71.82K | -$2.00K | -105.0% | +3490.8% |
| Discount - IsoPet [Member] | -$121.30K | – | -177.4% | – |
By region
From the segment and revenue-disaggregation notes of Vivos's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.